Synthesis and some of the pharmacological properties of (4-leucine)-8-lysine-vasopressin and (1-deamino,4-leucine)-8-lysine-vasopressin.
D000818:Animals; D002645:Chickens; D002855:Chromatography, Thin Layer; D003641:Deamination; D004231:Diuresis / Q000187:drug effects; D005260:Female; D007930:Leucine / Q000138:chemical synthesis / Q000494:pharmacology; D008239:Lysine / Q000138:chemical synthesis / Q000494:pharmacology; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D010121:Oxytocin / Q000037:antagonists & inhibitors; D010904:Pituitary Gland, Posterior / Q000187:drug effects; D051381:Rats; D014599:Uterus / Q000187:drug effects; D014667:Vasopressins / Q000138:chemical synthesis* / Q000494:pharmacology
D014667:Vasopressins; D010121:Oxytocin; D007930:Leucine; D008239:Lysine